NCT01243151 Safety And Tolerability Of Multiple Doses Of PF-04950615 (RN316) In Subjects With Hypercholesterolemia Status COMPLETED Phase PHASE1
NCT01242319 Translating ATP III Cholesterol Management Guidelines Into Primary Care Practice Status COMPLETED Phase N/A
NCT01236365 Statins in Children With Type 1 Diabetes and Hypercholesterolemia Status COMPLETED Phase PHASE3
NCT01228019 Niacin (+) Laropiprant (TREDAPTIVE) Re-examination Study (MK-0524A-119) Status TERMINATED Phase N/A
NCT01227330 Pilot Program to Improve Statin Adherence and Lower Cholesterol in Older Adults Status COMPLETED Phase PHASE1/PHASE2
NCT01222182 Statin Interchange by Pharmacist Collaborative Practice Agreement (CPA) Status COMPLETED Phase N/A
NCT01212900 Randomized Trial of Imaging Versus Risk Factor-Based Therapy for Plaque Regression Status COMPLETED Phase PHASE4
NCT01206231 An Epidemiological Study Aimed to Record Standard Daily Practice in Managing Patients With Hypercholesterolemia Status COMPLETED Phase N/A
NCT01190007 Open Label Study To Evaluate The Long-Term Safety Profiles Of Caduet In Japanese Patients Status COMPLETED Phase PHASE4
NCT01173939 Primary Prevention of Major Adverse Cardiac Events (MACE) With Standard and Intensive Statin Treatment in Patients With Diabetes: Survival and Cardiovascular Event Assessments Status TERMINATED Phase NA
NCT01166633 Efficacy and Safety Study of Pitavastatin Versus Atorvastatin to Treat Hypercholesterolemia Status COMPLETED Phase PHASE4
NCT01163851 Pharmacokinetic And Pharmacodynamic Study Of A Single-Dose Of PF-04950615 (RN316) In Combination With Atorvastatin Status COMPLETED Phase PHASE1
NCT01163838 Multiple-Dose Safety Study Of RN316 For TheTreatment Of Hypercholesterolemia Status WITHDRAWN Phase PHASE1
NCT01161082 Ascending Multi-dose Study of REGN727(SAR236553) With and Without Concomitant Atorvastatin Status COMPLETED Phase PHASE1
NCT01154036 MK0653C in High Cardiovascular Risk Patients With High Cholesterol (Switch Study)(MK-0653C-162) Status COMPLETED Phase PHASE3
NCT01126684 Effects of Atorvastatin on Blood Pressure and Urinary Albumin Excretion Status COMPLETED Phase NA
NCT01108978 Evaluating the Efficacy and Safety of Dehypotin® in the Patients With Type 2 Diabetes Mellitus or Cardiovascular Disease Status TERMINATED Phase PHASE4
NCT01107743 Amlodipine/Atorvastatin (Caduet®) Drug Use Investigation (Regulatory Post Marketing Commitment Plan) Status COMPLETED Phase N/A